Astrocytes produce interferon-alpha and CXCL10, but not IL-6 or CXCL8, in aicardi-Goutières syndrome
✍ Scribed by Jane T. Van Heteren; Flore Rozenberg; Eleonora Aronica; Dirk Troost; Pierre Lebon; Taco W. Kuijpers
- Book ID
- 102845695
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 745 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0894-1491
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Aicardi‐Goutières syndrome (AGS) presents as a severe autosomal recessively inherited neurological brain disease. Clinical and neurological manifestations closely resemble those of congenital viral infection and are generally attributed to a perturbation of innate immunity including a long lasting lymphocytosis and production of interferon‐alpha (IFNα) in the central nervous system. To clarify the innate immune response evoked in these diseases, we used a 30‐mer multiplexed luminex system to measure multiple cytokines and growth factors in the cerebrospinal fluid and serum of patients with AGS and viral meningitis or encephalitis, and febrile controls in whom infection could not be substantiated. In addition to the previously described IFNα, both AGS and viral diseases were characterized by expression of CXCL10 and CCL2. In contrast to AGS, viral infection resulted in high levels of IL‐6 and CXCL8 in the CNS. Postmortem immunohistochemical staining of brain sections showed that in both AGS and viral CNS infection, astrocytes were responsible for the production of cytokines and not the infiltrating leukocytes. In summary, our data indicate that astrocytes are the predominant cell type responsible for the production of IFNα and CXCL10 in AGS. Whereas IFNα is assumed to be involved in the neurodegeneration, calcifications and seizures in AGS, CXCL10 may act as the chemoattractant responsible for the influx of activated lymphocytes into the brain. The lack of the inflammatory cytokines IL‐6 and CXCL8 in AGS suggest that the neuroinflammatory reaction in this disease is distinct from viral disease. © 2008 Wiley‐Liss, Inc.